All
Immunotherapy Drug Extends Survival in Metastatic Melanoma
For metastatic melanoma patients who were out of treatment options, the immune system-targeted drug ipilimumab extended their lives by nearly four months compared with an investigational vaccine called gp100.
Chemotherapy Appropriate for Elderly Lung Cancer Patients
A large randomized study contradicted that notion in advanced non-small cell lung cancer when data showed that the standard combination chemotherapy, usually given to younger patients, was effective and safe in elderly patients.
A legacy made from lemonade
Amgen's Breakaway from Cancer panel tackles some complex issues at ASCO
A switch in breast cancer’s biology impacts treatment decisions
Attention oncologists: talk to your patients about treatment costs
New information from sentinel lymph node studies in breast cancer
Two drugs top Gleevec in newly diagnosed CML
How a family learns to live with metastatic cancer
ATLAS lung cancer trial fails to show survival benefit
Heart disease in childhood cancer survivors linked to gene variations
ASCO Update: New frontiers in personalized medicine--the Human Genome
New exercise guidelines for cancer survivors
New tool to personalize colorectal cancer treatment sees rapid adoption
ASCO & FDA partner to streamline expanded access process
TED talks about Angiogenesis
Integrating new therapies
What's coming at ASCO
Navigating the Maze of Disability
Navigating through the maze of disability insurance.
A night of grace and extraordinary healing
Scientists and survivors working together
When the mammogram is suspicious
For cancer survivors, a walk in the park
DCIS: An example of why screening and disease classification go hand-in-hand
"Finish Your Race" to help end acute myeloid leukemia
Sing for the Cure
Putting your health first
Finding hope and faith in cancer's despair
FDA approves first vaccine to treat cancer
Saying goodbye to someone I've never met
